
European Economic Area
European Economic Area
Northern IrelandBiocidal Products Regulation (BPR)CLP
This strategy aims to advance chemical safety through science, collaboration, and knowledge, emphasising the protection of human health and the environment.
Published in August 2024. Dates, deadlines and stages may have changed since.
3 min readAI-drafted, expert reviewed

The European Chemicals Agency (ECHA) has outlined its strategic goals and key areas of regulatory challenges for 2024-2028 under the framework of the Partnership for Assessment of Risks from Chemicals (PARC). This strategy aims to advance chemical safety through science, collaboration, and knowledge, emphasising the protection of human health and the environment. ECHA's updated strategy identifies critical research needs in several key areas, including protection against harmful chemicals, addressing chemical pollution, shifting away from animal testing, and improving the availability of chemical data.
ECHA has highlighted significant gaps in identifying and understanding the harmful effects of chemicals on the immune, neurological, and endocrine systems. The agency stresses the need for developing new test methods and understanding toxicological mechanisms to manage risks effectively. Key areas of concern include neurotoxicity, immunotoxicity, and endocrine disruption. ECHA calls for focused research to fill these gaps and facilitate regulatory actions.
Chemical pollution is a major driver of ecosystem degradation and biodiversity loss. ECHA emphasises the development of new approach methods (NAMs) for hazard and fate assessment of chemical substances. This includes understanding the sensitivity of non-bee pollinators to biocidal active substances and improving monitoring techniques. Bioaccumulation, a critical factor in environmental toxicity, also requires more detailed study and better regulatory methods.
ECHA is committed to reducing reliance on animal testing while ensuring that this transition does not compromise human health or environmental protection. The agency advocates for the development and validation of NAMs, such as in vitro and in silico methods, to replace current in vivo tests. This initiative covers various research areas, including read-across methods, ADME (absorption, distribution, metabolism, and excretion) studies, and models for assessing fish toxicity and carcinogenicity.
Effective chemical management in Europe depends on robust and relevant data. ECHA highlights the need for comprehensive information on polymers and nanomaterials. The agency also calls for improved analytical methods to ensure proper assessment of restricted chemicals. These efforts are crucial for making informed regulatory decisions and protecting human health and the environment.
Official source
echa.europa.eu
Dr Steven Brennan
CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.
More from Dr Steven BrennanForesight follows changes like this one and shows where they reach your substances, products and markets.

European Economic Area

European Economic Area

European Economic Area
Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.
Read by professionals at